Cancer Research UK Cancer Therapeutics Unit - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

News

ICR cancer drug NXP800 to enter Phase I trials

An investigational drug called NXP800, discovered at the Cancer Research UK Cancer Therapeutics Unit at London’s Institute of Cancer Research (ICR), is to enter Phas...

1 September 2021 News advanced cancers | Cancer Research UK Cancer Therapeutics Unit

Continue Reading →

Future-ready ADCs – advanced vial solutions for superior stability and performance

Alternative Drug Delivery Routes: Opportunities, Challenges, and How to Overcome Them

Bridging the gap between R&D and GMP

Current Edition

Current Edition

Subsection - CDMO

Subsection - Injectables

Subsection - Neurodegenerative Diseases

Subsection - Nasal & Pulmonary

ICR cancer drug NXP800 to enter Phase I trials

International Pharmaceutical Industry